Your browser doesn't support javascript.
loading
Low-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial.
Vanassche, Thomas; Verhamme, Peter; Anand, Sonia S; Shestakovska, Olga; Leong, Darryl P; Fox, Keith A A; Bhatt, Deepak L; Avezum, Alvaro; Alings, Marco; Aboyans, Victor; Maggioni, Aldo P; Widimsky, Petr; Muehlhofer, Eva; Berkowitz, Scott D; Yusuf, Salim; Connolly, Stuart J; Eikelboom, John W; Bosch, Jackie.
Afiliação
  • Vanassche T; Department of Cardiovascular Sciences, University Hospitals Leuven, KU Leuven, Herestraat 49, B-3000 Leuven, Belgium.
  • Verhamme P; Department of Cardiovascular Sciences, University Hospitals Leuven, KU Leuven, Herestraat 49, B-3000 Leuven, Belgium.
  • Anand SS; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada.
  • Shestakovska O; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada.
  • Leong DP; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada.
  • Fox KAA; Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
  • Bhatt DL; Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, MA, USA.
  • Avezum A; International Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.
  • Alings M; Amphia Ziekenhuis and Werkgroep Cardiologische Centra Nederland, Utrecht, the Netherlands.
  • Aboyans V; Department of Cardiology, Dupuytren University Hospital, and INSERM 1094 & IRD, Limoges University, Limoges, France.
  • Maggioni AP; Associazione Nazionale Medici Cardiologi Ospedalieri Research Center, Florence, Italy.
  • Widimsky P; Cardiocenter, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Muehlhofer E; Bayer AG, Wuppertal, Germany.
  • Berkowitz SD; Bayer U.S. LLC, Whippany, NJ, USA.
  • Yusuf S; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada.
  • Connolly SJ; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada.
  • Eikelboom JW; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada.
  • Bosch J; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada.
Eur Heart J Cardiovasc Pharmacother ; 8(5): 462-473, 2022 08 11.
Article em En | MEDLINE | ID: mdl-34191011
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rivaroxabana / Multimorbidade Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Eur Heart J Cardiovasc Pharmacother Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bélgica País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rivaroxabana / Multimorbidade Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Eur Heart J Cardiovasc Pharmacother Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bélgica País de publicação: Reino Unido